Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions

Lung Cancer ◽

10.1016/j.lungcan.2017.11.009 ◽

2018 ◽

Vol 115 ◽

pp. 12-20 ◽

Author(s):

Ross A. Soo ◽

Sun Min Lim ◽

Nicholas L. Syn ◽

Rebecca Teng ◽

Richie Soong ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Future Directions ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation

Cancer Communications ◽

10.1002/cac2.12229 ◽

2021 ◽

Author(s):

Lin Ma ◽

Bowen Diao ◽

Zhaoqin Huang ◽

Bin Wang ◽

Jinming Yu ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Immune Checkpoint Inhibitors ◽

Checkpoint Inhibitors ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth

Download Full-text

Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study

Geriatrics and Gerontology International ◽

10.1111/ggi.14243 ◽

2021 ◽

Author(s):

Yukari Tsubata ◽

Takeshi Masuda ◽

Kosuke Hamai ◽

Masaya Taniwaki ◽

Akari Tanino ◽

...

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Older Patients ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met

European Journal of Cancer ◽

10.1016/j.ejca.2021.09.039 ◽

2021 ◽

Vol 159 ◽

pp. 174-181

Author(s):

Margarita Majem ◽

Ivanna Sullivan ◽

Santiago Viteri ◽

Guillermo López-Vivanco ◽

Manuel Cobo ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant ◽

Allelic Fraction

Download Full-text

Targeting the metastatic niche through anti-angiogenic approaches in epidermal growth factor receptor mutant non-small cell lung cancer

Translational Lung Cancer Research ◽

10.21037/tlcr.2017.11.12 ◽

2018 ◽

Vol 7 (S1) ◽

pp. S13-S18

Author(s):

Wan Ling Tan ◽

Daniel S. W. Tan

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Metastatic Niche ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Brain surgery for epidermal growth factor receptor-mutant non-small-cell lung cancer with brain metastases

Annals of Oncology ◽

10.1093/annonc/mdy425.031 ◽

2018 ◽

Vol 29 ◽

pp. ix161

Author(s):

H.H. Lee ◽

M.-Y. Huang

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Brain Surgery ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer ◽

10.1002/cncr.32744 ◽

2020 ◽

Vol 126 (9) ◽

pp. 2024-2033 ◽

Author(s):

Hongjing Zang ◽

Guoqing Qian ◽

Dan Zong ◽

Songqing Fan ◽

Taofeek K. Owonikoko ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Histone Deacetylase Inhibitor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Deacetylase Inhibitor ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non–Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy

Clinical Lung Cancer ◽

10.1016/j.cllc.2016.12.013 ◽

2017 ◽

Vol 18 (3) ◽

pp. e169-e178 ◽

Author(s):

Yu Jin Lim ◽

Ji Hyun Chang ◽

Hak-Jae Kim ◽

Bhumsuk Keam ◽

Tae Min Kim ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Concurrent Chemoradiotherapy ◽

Growth Factor Receptor ◽

Tumor Control ◽

Small Cell Lung ◽

Mutant Genotype ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic non-small-cell lung cancer

Medicine ◽

10.1097/md.0000000000027279 ◽

2021 ◽

Vol 100 (37) ◽

pp. e27279

Author(s):

Xia Wang ◽

Zhiqin Lu ◽

Zhimin Zeng ◽

Jing Cai ◽

Peng Xu ◽

...

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Kinase Inhibitors ◽

Stereotactic Body Radiation Therapy ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Management of brain metastases in epidermal growth factor receptor-mutant non-small-cell lung cancer: A retrospective multi-institutional analysis

Annals of Oncology ◽

10.1093/annonc/mdy425.035 ◽

2018 ◽

Vol 29 ◽

pp. ix162

Author(s):

C.H. Chen ◽

M.-Y. Huang ◽

I.-W. Chong

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastases ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text

Utilizing Publicly Available Cancer Clinicogenomic Data on CBioPortal to Compare Epidermal Growth Factor Receptor Mutant and Wildtype Non-Small Cell Lung Cancer

Cureus ◽

10.7759/cureus.14683 ◽

2021 ◽

Author(s):

Chirag Dhar

Keyword(s):

Lung Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell Lung ◽

Epidermal Growth ◽

Receptor Mutant

Download Full-text